Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation

Petter Isakson, Ann Hammarstedt, Birgit Gustafson, Ulf Smith, Petter Isakson, Ann Hammarstedt, Birgit Gustafson, Ulf Smith

Abstract

Objective: We examined preadipocyte differentiation in obese and nonobese individuals and the effect of cytokines and wingless-type MMTV (mouse mammary tumor virus) integration site family, member 3A (Wnt3a) protein on preadipocyte differentiation and phenotype.

Research design and methods: Abdominal subcutaneous adipose tissue biopsies were obtained from a total of 51 donors with varying BMI. After isolation of the adipose and stromalvascular cells, inflammatory cells (CD14- and CD45-positive cells) were removed by immune magnetic separation. CD133-positive cells, containing early progenitor cells, were also isolated and quantified. The CD14- and CD45-negative preadipocytes were cultured with tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, resistin, or Wnt3a with or without a differentiation cocktail.

Results: The number of preadipocytes able to differentiate to adipose cells was negatively correlated with both BMI and adipocyte cell size of the donors, whereas the number of CD133-positive cells was positively correlated with BMI, suggesting an impaired differentiation of preadipocytes in obesity. Cultured preadipocytes, like freshly isolated mature adipocytes, from obese individuals had an increased expression of mitogen-activated protein 4 kinase 4 (MAP4K4), which is known to inhibit peroxisome proliferator-activated receptor-gamma induction. TNF-alpha, but not IL-6 or resistin, increased Wnt10b, completely inhibited the normal differentiation of the preadipocytes, and instead induced a proinflammatory and macrophage-like phenotype of the cells.

Conclusions: The apparent number of preadipocytes in the abdominal subcutaneous tissue that can undergo differentiation is reduced in obesity with enlarged fat cells, possibly because of increased MAP4K4 levels. TNF-alpha promoted a macrophage-like phenotype of the preadipocytes, including several macrophage markers. These results document the plasticity of human preadipocytes and the inverse relationship between lipid storage and proinflammatory capacity.

Figures

FIG. 1.
FIG. 1.
Impaired differentiation of human preadipocytes from obese donors. A: mRNA expression of GLUT4 and adiponectin (Apm1) before (□ = 1) and after (■) adipocyte differentiation. Data are the means ± SE from six different subjects. *P < 0.05. B: Oil red O staining (absorbance) of primary human preadipocytes differentiated for 21 days from two different donors with varying percentage of differentiation. C: BMI of the preadipocyte donor is significantly and inversely correlated to the degree of preadipocyte differentiation (R2 = 0.59, P = 0.006). D: Correlation between preadipocyte differentiation and mean adipocyte size of the donors (R2 = 0.69, P < 0.001). E: The relative number of CD133-positive cells in the stromal vascular fraction is positively correlated with BMI of the donor (R2 = 0.51, P < 0.01). F: mRNA levels of MAP4K4 in cultured preadipocytes in relation to BMI of the donors (R2 = 0.42, P < 0.05). G and H: Correlation between MAP4K4 mRNA levels in isolated mature adipose cells and BMI (R2 = 0.41, P < 0.04) (G) or waist-to-hip ratio (WHR) (H) of the donors (R2 = 0.67, P = 0.002). Abs, absorbance; RQ, relative quantification.
FIG. 2.
FIG. 2.
TNF-α and Wnt3a inhibit the differentiation of human preadipocytes. A: The presence of TNF-α induces proliferation of primary human preadipocytes. B: The presence of either TNF-α (5 ng/ml) or Wnt3a (∼50 ng/ml) completely prevented normal adipocyte differentiation, as shown by oil red O staining. C: mRNA expression of GLUT4, adiponectin (Apm1), and Wnt10 after adipocyte differentiation for 21 days in the absence (□) or presence of TNF-α (5 ng/ml) (■). Data are the means ± SE from 11 different subjects. *P < 0.05. D: Oil red O staining of human preadipocytes differentiated for 21 days with or without preincubation with TNF-α (5 ng/ml) for 10 days. Bas, basal; RQ, relative quantification.
FIG. 3.
FIG. 3.
Human preadipocytes assume a macrophage-like phenotype in the presence of TNF-α. Levels of secreted inflammatory molecules by human preadipocytes untreated (□) or treated with TNF-α (5 ng/ml) (■), IL-6 (20 ng/ml) (▥), or human resistin (50 ng/ml) (▨) for 10 days. Data are the means ± SE from six different subjects. *P < 0.05; ***P < 0.001.

References

    1. Bjorntorp P: Effects of age, sex, and clinical conditions on adipose tissue cellularity in man. Metabolism 1974; 23: 1091– 1102
    1. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Naslund E, Britton T, Concha H, Hassan M, Ryden M, Frisen J, Arner P: Dynamics of fat cell turnover in humans. Nature 2008; 453: 783– 787
    1. Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T: Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998; 101: 1354– 1361
    1. Tontonoz P, Hu E, Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994; 79: 1147– 1156
    1. Bjorntorp P: Fat cell distribution and metabolism. Ann N Y Acad Sci 1987; 499: 66– 72
    1. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW: Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54: 254– 260
    1. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U: Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution. J Clin Invest 1983; 72: 1150– 1162
    1. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796– 1808
    1. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821– 1830
    1. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, Wang S, Fortier M, Greenberg AS, Obin MS: Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005; 46: 2347– 2355
    1. Dahlman I, Kaaman M, Olsson T, Tan GD, Bickerton AS, Wahlen K, Andersson J, Nordstrom EA, Blomqvist L, Sjogren A, Forsgren M, Attersand A, Arner P: A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab 2005; 90: 5834– 5840
    1. Nomiyama T, Perez-Tilve D, Ogawa D, Gizard F, Zhao Y, Heywood EB, Jones KL, Kawamori R, Cassis LA, Tschop MH, Bruemmer D: Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 2007; 117: 2877– 2888
    1. Han CY, Subramanian S, Chan CK, Omer M, Chiba T, Wight TN, Chait A: Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion. Diabetes 2007; 56: 2260– 2273
    1. Gustafson B, Hammarstedt A, Andersson CX, Smith U: Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27: 2276– 2283
    1. Lumeng CN, Bodzin JL, Saltiel AR: Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175– 184
    1. Guilherme A, Virbasius JV, Puri V, Czech MP: Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9: 367– 377
    1. Hotamisligil GS: Inflammation and metabolic disorders. Nature 2006; 444: 860– 867
    1. Gustafson B, Smith U: Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3–L1 preadipocytes. J Biol Chem 2006; 281: 9507– 9516
    1. Rotter V, Nagaev I, Smith U: Interleukin-6 (IL-6) induces insulin resistance in 3T3–L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003; 278: 45777– 45784
    1. Sevastianova K, Sutinen J, Kannisto K, Hamsten A, Ristola M, Yki-Jarvinen H: Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy. Am J Physiol Endocrinol Metab 2008; 295: E85– E91
    1. Chung S, Lapoint K, Martinez K, Kennedy A, Boysen Sandberg M, McIntosh MK: Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 2006; 147: 5340– 5351
    1. Charriere G, Cousin B, Arnaud E, Andre M, Bacou F, Penicaud L, Casteilla L: Preadipocyte conversion to macrophage: evidence of plasticity. J Biol Chem 2003; 278: 9850– 9855
    1. Soukas A, Socci ND, Saatkamp BD, Novelli S, Friedman JM: Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J Biol Chem 2001; 276: 34167– 34174
    1. Tang X, Guilherme A, Chakladar A, Powelka AM, Konda S, Virbasius JV, Nicoloro SM, Straubhaar J, Czech MP: An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARgamma, adipogenesis, and insulin-responsive hexose transport. Proc Natl Acad Sci U S A 2006; 103: 2087– 2092
    1. Tesz GJ, Guilherme A, Guntur KV, Hubbard AC, Tang X, Chawla A, Czech MP: Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2. J Biol Chem 2007; 282: 19302– 19312
    1. Kumar BM, Yoo JG, Ock SA, Kim JG, Song HJ, Kang EJ, Cho SK, Lee SL, Cho JH, Balasubramanian S, Rho GJ: In vitro differentiation of mesenchymal progenitor cells derived from porcine umbilical cord blood. Mol Cells 2007; 24: 343– 350
    1. Gordon PR, Leimig T, Babarin-Dorner A, Houston J, Holladay M, Mueller I, Geiger T, Handgretinger R: Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells. Bone Marrow Transplant 2003; 31: 17– 22
    1. Cawthorn WP, Heyd F, Hegyi K, Sethi JK: Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin/TCF4(TCF7L2)-dependent pathway. Cell Death Differ 2007; 14: 1361– 1373
    1. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW: Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273– 2282
    1. Fried SK, Bunkin DA, Greenberg AS: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83: 847– 850
    1. Di Gregorio GB, Yao-Borengasser A, Rasouli N, Varma V, Lu T, Miles LM, Ranganathan G, Peterson CA, McGehee RE, Kern PA: Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 2005; 54: 2305– 2313
    1. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS: TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015– 3025
    1. Permana PA, Nair S, Lee YH, Luczy-Bachman G, Vozarova De Courten B, Tataranni PA: Subcutaneous abdominal preadipocyte differentiation in vitro inversely correlates with central obesity. Am J Physiol Endocrinol Metab 2004; 286: E958– E962
    1. Tchoukalova Y, Koutsari C, Jensen M: Committed subcutaneous preadipocytes are reduced in human obesity. Diabetologia 2007; 50: 151– 157
    1. Yang X, Smith U: Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? Diabetologia 2007; 50: 1127– 1139
    1. Hammarstedt A, Isakson P, Gustafson B, Smith U: Wnt-signaling is maintained and adipogenesis inhibited by TNFalpha but not MCP-1 and resistin. Biochem Biophys Res Commun 2007; 357: 700– 706

Source: PubMed

3
Subscribe